Abstract
p33/ING1s (the growth inhibitor ING1 and candidate tumor suppressor ING1) are key players in the suppressive pathways for human tumorigenesis. We analyzed their complete transcripts, primary structures, and expression. The results led us to discover two novel and related alternatively spliced transcripts encoding p24/ING1-ALT1 and p47/ING1-ALT2. They share C-terminal residues with the candidate tumor suppressors p33/ING1. The candidate tumor suppressors p33/ING1 and p24/ING1-ALT1 were coexpressed in a variety of fetal and adult human tissues, but p47/ING1-ALT2 was minimally expressed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: November 12, 1999 / Accepted: December 20, 1999
Rights and permissions
About this article
Cite this article
Saito, A., Furukawa, T., Fukushige, S. et al. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1. J Hum Genet 45, 177–181 (2000). https://doi.org/10.1007/s100380050206
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380050206
This article is cited by
-
The expression of p33ING1, p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer
Tumor Biology (2011)
-
The ING family tumor suppressors: from structure to function
Cellular and Molecular Life Sciences (2011)
-
Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas
Oncogene (2006)
-
A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis
Oncogene (2003)